Search results
Beximco Pharmaceuticals Ltd (BPL) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of USA, Australia, European Union, Canada, and Brazil, among others.
- About
About - Beximco Pharmaceuticals Ltd.
- Products
Products - Beximco Pharmaceuticals Ltd.
- Investors
Investors - Beximco Pharmaceuticals Ltd.
- Health
Health - Beximco Pharmaceuticals Ltd.
- Newsroom
Newsroom - Beximco Pharmaceuticals Ltd.
- Contact
Contact - Beximco Pharmaceuticals Ltd.
- Company Information
Company Information - Beximco Pharmaceuticals Ltd.
- Financial Reports
Financial Reports - Beximco Pharmaceuticals Ltd.
- About
Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. BPL is the largest exporter of generic drugs in the country and its state-of-the-art manufacturing facilities are already certified by major global regulatory authorities like TGA, GCC and ANVISA, while awaiting audits and approvals by US FDA ...
Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. [5] Today, Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS , cancer , asthma , hypertension , and diabetes for both national and international markets.
Beximco Pharmaceuticals Ltd (Beximco Pharma) is an emerging generic drug player committed to providing access to affordable medicines. Company’s state-of-the-art manufacturing facilities have been accredited by the regulatory authorities of Australia, European Union, Canada, and Brazil, among others, and it currently focuses on building presence in many emerging and developed markets around ...
Oct 11, 2024 · Beximco Pharmaceuticals Limited is a Bangladesh-based company which is a manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The Company is engaged in manufacturing and marketing of generic pharmaceutical formulation products covering a range of therapeutic categories.
2 days ago · In 2023, Beximco Pharmaceuticals's revenue was 39.27 billion, an increase of 13.26% compared to the previous year's 34.67 billion. Earnings were 4.61 billion, a decrease of -9.94%. Financial Statements
People also ask
Who is Beximco Pharmaceuticals Ltd (BPL)?
Who is Beximco Pharmaceuticals Ltd?
Does Beximco Pharma sell generic drugs?
How did Beximco Pharma start?
Why is CSR important for Beximco Pharmaceuticals Ltd (BPL)?
Does Beximco Pharma own Sanofi?
BEXIMCO PHARMACEUTICALS LIMITED BXP Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.
